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Long-term (72 hr) exposure of pancreatic islets to
palmitate inhibited glucose-induced insulin secretion
by>50%withfirst- andsecond-phasesecretionbeing
equally suppressed. This inhibition correlated with
the selective impairment of exocytosis evoked by
brief (action potential-like) depolarizations, whereas
that evoked by long (250 ms) stimuli was unaf-
fected. Under normal conditions, Ca2+ influx elicited
by brief membrane depolarizations increases [Ca2+]i
to high levels within discrete microdomains and trig-
gers the exocytosis of closely associated insulin
granules. We found that these domains of localized
Ca2+ entry become dispersed by long-term (72 hr),
but not by acute (2 hr), exposure to palmitate. Impor-
tantly, the release competence of the granules was
not affected by palmitate. Thus, the location rather
than the magnitude of the Ca2+ increase determines
its capacity to evoke exocytosis. In both mouse and
human islets, the palmitate-induced secretion defect
was reversed when the b cell action potential was
pharmacologically prolonged.
INTRODUCTION
Type 2 diabetes mellitus is characterized by insufficient insulin
secretion in response to elevations of plasma glucose (Weyer
et al., 1999). This decreased insulin response shows a strong
correlation with obesity (Kahn et al., 2006) and elevated plasma
levels of free fatty acids (FFAs) (Boden, 2002). Protracted expo-
sure to FFAs results in marked suppression of glucose-induced
insulin secretion both in vivo and in vitro (Sako and Grill, 1990;
Zhou and Grill, 1994). Although the latter effect has been exten-
sively characterized, the cellular mechanisms remain enigmatic
(Poitout and Robertson, 2008). The adverse effects of FFAs on
b cell function, often referred to as ‘‘lipotoxicity’’ (Lee et al.,
1994), have been postulated to culminate in b cell death. Indeed,
experiments on human cells in vitro demonstrated marked
apoptosis after just 24 hr exposure to elevated FFAs and glucose
(El-Assaad et al., 2003). Apoptosis of b cells has been attributedCell Mto both oxidative stress (Morgan et al., 2007) and ER stress
(Kharroubi et al., 2004) as well as other pathways (Cnop et al.,
2005). However, other studies have failed to find evidence of
any significant apoptosis following long-term exposure to FFAs
(Kelpe et al., 2003). These discrepancies have been attributed
to differences in the levels of unbound FFAs or islet viability (Poit-
out and Robertson, 2008).
In healthy b cells, elevation of glucose produces (via its metab-
olism) an increased cytoplasmic ATP/ADP ratio and closure of
ATP-regulated K+ channels (KATP channels). This causes mem-
brane depolarization and the opening of voltage-dependent
Ca2+ channels. The resultant increase in [Ca2+]i triggers the exo-
cytosis of insulin-containing granules. This secretory response
consists of a rapid but transient first phase followed a slowly
developing second phase (Henquin et al., 2002). Exocytosis
during brief (action potential-like) depolarizations primarily
involves granules belonging to a readily releasable pool (RRP)
in close proximity to the voltage-gated Ca2+ channels (Barg
et al., 2001). In a previous study (Olofsson et al., 2007), we re-
ported that inhibition of glucose-stimulated insulin secretion by
long-term exposure to the FFAs oleate and palmitate occurred
without any signs of increased b cell death, reduced insulin
synthesis, impaired glucose metabolism, KATP channel regula-
tion, or Ca2+ signaling. It was therefore proposed that the pertur-
bation occurs at the level of exocytosis. Here we have examined
this possibility in greater detail by measurements of lipid compo-
sition, membrane fluidity, imaging of submembrane [Ca2+]i, and
exocytosis.
RESULTS
Effects of Palmitate on Islet mRNA Content
The effects of long-term palmitate treatment on the amounts of
mRNA encoding key proteins involved in granule priming and
exocytosis were evaluated by quantitative PCR (qPCR; see
Table S1 available online). No major changes in gene transcrip-
tion were observed that would account for the strong inhibition
of insulin secretion observed (Olofsson et al., 2007).
Analysis of Palmitate Processing and Storage
by Pancreatic Islets
Changes in the lipid composition have been shown to affect the
energy requirements of membrane fusion (Chernomordik andetabolism 10, 455–465, December 2, 2009 ª2009 Elsevier Inc. 455
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phospholipid (PL) and triglyceride (TG) composition of palmi-
tate-treated and control islets. The palmitate content of the
phospholipid fraction increased by 3–4 mol%, and stearate
content correspondingly decreased in islet exposed to palmitate
(see definition in the Experimental Procedures) (Figure 1A).
These changes are much larger than those observed in erythro-
cytes from animals fed a high-fat diet (Poppitt et al., 2005). The
overall ratio of saturated to unsaturated fatty acids in the phos-
pholipid fraction remained unaltered when comparing control
and palmitate-treated groups (0.88 ± 0.03 and 0.81 ± 0.03; p <
0.13; n = 4). Exposure of islets to palmitate resulted in a >3-
fold increase in overall TG levels (Figure 1B, inset). Whereas
the palmitate content of the triglyceride fraction increased by
50%, the stearate content was reduced by one third. These
findings are in good agreement with a previous study that
measured total changes in fatty acid composition in MIN6 clonal
cells (Busch et al., 2005).
We also made use of uniformly labeled (U13C) palmitate (Hod-
son et al., 2009) to track the incorporation of exogenous palmi-
tate into phospholipids and triglycerides. In islets exposed
to exogenous 13C-labeled palmitate for 72 hr, a significant
amount of 13C-labeled palmitate was converted into phospho-
lipids (Figure 1C), as well as some expected deposition as TGs
(Figure 1D). Thus, palmitate is not simply deposited inside the
b cell but is actively processed (by both desaturation and elonga-
tion) and is converted into phospholipids, the major component
of the plasma membrane. No incorporation of palmitate into
Figure 1. Pancreatic Islet Lipid Analysis
(A) Proportion of individual phospholipid fatty
acids in control (black) and palmitate-treated
(red) islets.
(B) Proportion of individual triglyceride fatty acids
in control (black) and palmitate-treated (red) islets.
The inset shows total TGs in islets exposed, or not,
to palmitate.
(C and D) Amounts of uniformly labeled 13C phos-
pholipids (C) and triglycerides (D) per islet during
72 hr treatment with exogenous 13C-labeled pal-
mitate. All phospholids and triglycerides labeled
with 13C originate from 13C-labeled exogenous
palmitate. All experiments were performed four
times with a minimum of 220 islets per group.
For each experiment, islets isolated from six
mice were pooled and divided evenly into the
two pools that were cultured for 72 hr in the
absence or presence of palmitate. All error bars
are ±SEM, *p < 0.05; **p < 0.01.
phospholipid was observed during a 2
hr incubation (data not shown).
Membrane Fluidity Is Not Affected
by Palmitate Treatment
Impaired insulin exocytosis may be sec-
ondary to changes in membrane fluidity
resulting from the altered phospholipid
composition. We therefore examined
membrane fluidity by analyzing lipid
mobility by fluorescence recovery after photobleaching (FRAP).
Pancreatic b cells isolated from islets incubated for 72 hr in
the presence or absence of palmitate were labeled with the
14-carbon lipids fluorescently tagged with individual BODIPY
fluorophores. No palmitate-induced changes in membrane
fluidity were detected by this method (Figure S1).
Loss of Localized Ca2+ Influx Following Palmitate
Treatment
Exocytosis of insulin granules depends on localized increases in
[Ca2+]i close to the voltage-gated Ca
2+-channels (Barg et al.,
2001). We examined the effects of palmitate exposure on b cell
Ca2+ channel distribution by measurements of near-plasma
membrane [Ca2+]i transients elicited by 50 ms depolarizations
from 70 to 0 mV using the low-affinity Ca2+ indicator Oregon
Green 6F (Figure 2A). This strategy was chosen as the Ca2+
channel density in mouse b cells is too low to allow immunocyto-
chemical studies of Ca2+ channel distribution. Line scans
obtained along the white lines are shown for one control cell
and one palmitate-treated cell (Figure 2B). Whereas membrane
depolarization produced discrete regions with high [Ca2+]i in
control cells, the increase in [Ca2+] was more diffuse in palmi-
tate-treated cells and did not attain as high concentrations. To
quantify this, we calculated the coefficient of variation (CV) of
theCa2+ signal in the entire cell footprint; a greater spatial hetero-
geneity will produce a higher CV. This analysis revealed that
depolarization-evoked [Ca2+]i (labeled ‘‘0’’) is significantly less
compartmentalized in palmitate-treated b cells than in control456 Cell Metabolism 10, 455–465, December 2, 2009 ª2009 Elsevier Inc.
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FFAs and b Cell FunctionFigure 2. TIRF Imaging Reveals a Redistribution of Ca2+ Influx Sites in Cells after Palmitate Treatment
(A) Evanescent field illumination of voltage-clamped cells infused with EGTA (10 mM) stimulated by a single 50 ms depolarization from 70 to 0 mV. Changes in
[Ca2+]i are displayed in pseudocolors with black/blue and yellow/red corresponding to very low and high concentrations, respectively. Scale bars, 2 mm.
(B) Line scans taken through the cells as illustrated by dashed white lines in (A). Calibration bar (right) is the same as in (A). Note that increases in [Ca2+]i are local-
ized and large in control cells, whereas they are more spread out and smaller after palmitate treatment.
(C) CV of the Oregon Green 6F fluorescence ([Ca2+]i) during a 50 ms depolarization to 0 mV (0), and at rest (70) for control cells (black, n = 6), cells treated
with palmitate for 72 hr (red, n = 8), and cells treated with palmitate for 2 hr after a 72 hr culture period under control conditions (blue; n = 6). All error bars
are ±SEM, *p < 0.05.cells (Figure 2C). However, resting [Ca2+]i prior to depolarization
(labeled ‘‘70’’) was not different between control and palmi-
tate-treated cells. The latter finding argues that the observed
effect on depolarization-evoked Ca2+ influx cannot be attributed
to differences in plasmamembrane adherence to the coverslip or
dye infusion. We ascertained that the amount of Ca2+-sensitiveCell Mdye infused into the cell did not differ between the two conditions
(data not shown; p = 0.35). The redistribution of [Ca2+]i was only
observed in response to long-term palmitate exposure and in
b cells that were first cultured under control conditions for 72 hr
and then exposed to palmitate for 2 hr, the measured CV
remained the same as in control cells both at 70 and 0 mV.etabolism 10, 455–465, December 2, 2009 ª2009 Elsevier Inc. 457
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FFAs and b Cell FunctionFigure 3. Chronic Palmitate Treatment
Alters Exocytosis as Measured by Optical
and Electrophysiological Methods in Single
b Cells
(A) Exocytosis (monitored as changes in mem-
brane capacitance, DCm) plotted against pulse
duration (t) for both control (black, n = 7) and
palmitate-treated (red, n = 9; *p < 0.05) cells. The
inset compares exocytotic responses elicited by
a 50 or 250 ms depolarization in control (black)
and palmitate-treated (red) cells.
(B) Exocytosis (DCm; middle) and normalized sub-
membrane [Ca2+]i signals (DF/F; bottom) evoked in
control cells (black) and palmitate-treated cells
(red) by a train of ten 40 ms depolarizations from
70 to 10 mV (6.67 Hz; top).
(C and D) Percentage of granules (%NIAPP) visible
in the cell footprint released during trains of ten
40ms (same as in B) or ten 500ms depolarizations
(1 Hz; D) for control (black, n = 7) and palmitate-
treated (red, n = 8) cells (*p < 0.05).
(E) Granule density measured in control (black)
and palmitate-treated (red) cells prior to stimula-
tion. Same cells as in (B)–(D).
(F) Single fusion events from control (top) and
palmitate-treated (lower) cells recorded at 20 Hz.
Each frame is 1 mm.
(G) DF/F IAPP-mCherry signal in control (black)
and palmitate-treated (red) cells. Both traces are
time-aligned averages of 15 fusion events
recorded in three control and three palmitate-
treated cells. Images and data points in (F)
and (G) have been aligned. All error bars are
±SEM.The amplitude of the whole-cell Ca2+ current is not affected by
exposure to palmitate (Olofsson et al., 2007). Likewise, there is
no change in the relative contribution of L-type Ca2+ channels;
the L-type Ca2+ channel blocker isradipine (10 mM) reduced
the whole-cell Ca2+ current by 55% ± 13% (n = 4) and 57% ±
10% (n = 4) in control and palmitate-treated cells, respectively.
Thus, the observed changes in Ca2+ entry are likely to reflect
redistribution of Ca2+ channels rather than altered subtype
expression/magnitude of the Ca2+ current. This conclusion is in
agreement with the qPCR data (Table S1).
In separate experiments, we analyzed the distribution of syn-
taxin-1a in control and palmitate-treated cells; no difference
was observed (CV = 0.17 ± 0.01 and 0.16 ± 0.01 in control and
palmitate-treated cells, respectively; Figure S2). Palmitate was
likewise without effect on the membrane distribution of SNAP-
25 (data not shown).
Inhibition of Rapid Exocytosis in Palmitate-TreatedCells
What are the effects of Ca2+ channel redistribution on exocy-
tosis? Figure 3A shows increases in membrane capacitance
(DCm) measurements from control and palmitate-treated cells
when exocytosis was elicited by progressively longer
(25–500 ms) depolarizations from 70 to 0 mV. The inset
compares the responses in control cells (black) and palmitate-
treatedcells (red) during 50and250msdepolarizations.Whereas
a substantial (>50%–80%) decrease was observed in palmitate-
treated cells during short (<100 ms) depolarizations, no signifi-
cant inhibition was detected during depolarizationsR250 ms.458 Cell Metabolism 10, 455–465, December 2, 2009 ª2009 ElsevieWe next optically measured exocytosis of individual granules
in parallel with measurements of submembrane [Ca2+]i and
DCm in b cells expressing a fluorescently tagged variant of the
granule protein IAPP (IAPP-mCherry; Figure S3). Exocytosis
was elicited using a pulse protocol simulating glucose-induced
b cell electrical activity that consisted of ten 40 ms depolariza-
tions from 70 to 10 mV. The total DCm evoked by the train
was reduced by 55% (Figure 3B), from 118 ± 39 fF (n = 7) under
control conditions to 48 ± 18 fF (n = 8; p < 0.05) after palmitate
exposure. This inhibition of exocytosis occurred without any
changes in overall [Ca2+]i (compare red and black traces in the
lower panel of Figure 3B (p > 0.5). Inhibition of exocytosis was
also detected in the optical measurements. In control cells, 5%
of the proximal (near-membrane) granules underwent exocytosis
and released their fluorescent cargo during the train as com-
pared to 1.5% in cells cultured in the presence of palmitate
(Figure 3C). By contrast, no palmitate-induced inhibition of
exocytosis was detectable when stimulation was elicited by
depolarization of a supraphysiological duration (ten 500 ms
depolarizations to zero mV; Figure 3D). Under these conditions,
the total DCm averaged 425 ± 61 fF (n = 7) and 432 ± 82 fF (n = 8)
in control cells and palmitate-treated cells, respectively. In the
fluorescent imaging experiments, 20%–25% of the docked
granules were released during the train in both control and palmi-
tate-treated cells (Figure 3D). The suppression of exocytosis by
action potential-like stimulation in palmitate-treated cells cannot
be accounted for by a dearth of available granules, which aver-
aged 0.7 granules/mm2 in both control and palmitate-treatedr Inc.
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that reported by others in human b cells (Michael et al., 2007)
but different from that reported previously in rat b cells (Tsuboi
et al., 2006).
Figure 3F compares the exit of the IAPP-mCherry cargo in
both control (top) and palmitate-treated cells (bottom). In both
cases, granule emptying is complete within four to five frames
(<250 ms). Figure 3G depicts the average time courses of
granule emptying in control (black) and palmitate-treated cells.
The initial increase reflects the discharge of fluorescent peptide
cargo into the space between the coverslip and the cell
membrane, which then rapidly decays to background values
as the fluorescent proteins diffuse away from the cell. Thus,
FFA pretreatment does not, contrary to what was previously
hypothesized (Olofsson et al., 2007), inhibit insulin secretion by
interfering with the emptying of the granules.
Figure 4. Decoupling of Ca2+ Entry Sites
from Docked Secretory Granules Selec-
tively Impairs Fast Exocytosis
(A) Image of a single control b cell expressing
IAPP-mCherry. The white and purple circles indi-
cate granules that did or did not undergo exocy-
tosis, respectively. The inset (lower right corner)
shows the increase in [Ca2+]i (DF) 33 ms after the
onset of the 800 ms depolarization from 70 to
10mV after subtraction of the resting Ca2+ signal
in the same cell. Scale bars, 2.5 mm.
(B) Same as in (A), but using a palmitate-treated
cell.
(C and D) Ca2+ increases (normalized to resting;
DF/F) within the white (exocytosing granules) and
purple (nonexocytosing granules) circles. Data
are averages of 98 events in 10 control cells and
81 events in 10 palmitate-treated cells, respec-
tively (*p < 0.05).
(E) Percentage of docked granules (NIAPP) in
control (black) and palmitate-treated (red) cells
that have undergone exocytosis displayed against
time after onset of the depolarization (p < 0.05).
Data were obtained from the same cells as in (C)
and (D). Dotted lines indicate the rate of secretion
measured >50 ms after the onset of the depolar-
izations. The slope of the lines is the same in
control and palmitate-treated cells (p > 0.60). All
error bars are ±SEM.
Effects of Palmitate Exposure
in Relation to Pools of Granules
Granules within secretory cells belong to
different functional pools (Becherer and
Rettig, 2006). In addition to a RRP of
granules situated close to the Ca2+ chan-
nels, b cells possess a slowly releasable
pool (SRP) of granules that are molecu-
larly similar to the RRP but geographically
separated from sites of Ca2+ entry (Barg
et al., 2001; Pertusa et al., 1999). To test
the hypothesis that chronic palmitate
exposure interferes with the coupling
between the Ca2+ channels and granules
undergoing rapid exocytosis, we simulta-
neously measured the rate of exocytosis and changes in sub-
membrane [Ca2+]i during an 800 ms depolarization (see Movie
S1). Circular regions with a diameter of 1 mm were centered on
each granule that underwent exocytosis during this period (white
circles, Figures 4A and 4B). These regions were then used to
measure the local increases in [Ca2+]i for each exocytosing
granule. The [Ca2+]i changes (insets) in these regions were
compared to that of adjacent stationary granules (purple circles).
In control cells, granules that underwent exocytosis had an
45% larger increase in local [Ca2+]i than those that were not
released (p < 0.05, Figure 4C). No such difference existed for
palmitate-treated cells (Figure 4D). We analyzed the conse-
quence of this on the kinetics of exocytosis (Figure 4E). In control
cells, 2% of the proximal granules discharged their peptide
cargo during the first 100 ms of the depolarization, compared
to <0.3% in palmitate-treated cells (an inhibition of >85%).Cell Metabolism 10, 455–465, December 2, 2009 ª2009 Elsevier Inc. 459
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control and palmitate-treated cells.
Increased Sensitivity to Intracellular Ca2+ Buffering
in Palmitate-Treated Cells
The data of Figure 4E support the notion that control cells
contain both RRP (close to Ca2+ channels) and SRP (further
away from the Ca2+ channels) granules, whereas palmitate-
treated cells contain only SRP granules. Exocytosis of these
two pools of granules should be differentially influenced by
Ca2+ buffering; exocytosis of granules situated far away from
the Ca2+ channels should be inhibited by the slow Ca2+ buffer
EGTA, whereas granules residing in close proximity to the Ca2+
channels should be less affected (Marty and Neher, 1985).
Figure 5A compares [Ca2+]i increases elicited by a 50 (Figure 5Aa)
and a 500 ms (Figure 5Ab) depolarization (0 mV) in a b cell
dialyzed with 50 mM EGTA. Under these conditions, a longer
depolarization expands [Ca2+]i microdomains. Thus, there is
a progressive increase in submembrane [Ca2+]i (measured as
DF/F) beyond that attained during the first 50 ms that reflects
the intracellular diffusion of Ca2+. By contrast, the microdomains
did not expand with pulse duration when the cells were infused
with 10 mM EGTA (Figures 5Ca and 5Cb). Consequently, the
increase in DF/F was maximal at 50 ms (Figure 5D).
In cells containing 50 mMEGTA, exocytosis evoked by 500 ms
depolarizations was unaffected by palmitate, whereas the
response to the 50 ms depolarization was reduced by 68% after
palmitate treatment (Figure 5E; same data as in Figure 3A). When
intracellular Ca2+ diffusion was restricted by including 10 mM
EGTA in the intracellular solution, the amplitude of the response
elicited by 500 ms depolarizations was reduced and became
comparable to that evoked by a 50 ms depolarization at low
intracellular buffering. Under these conditions, exocytosis
elicited by the 500 ms depolarization was inhibited by 70% in
palmitate-treated cells (inset). We conclude that the time- and
diffusion-dependent expansion of the [Ca2+]i domain explains
why palmitate does not inhibit exocytosis elicited by longer
depolarizations at low intracellular Ca2+ buffering.
Differential Effects of Palmitate on Exocytosis Evoked
by Localized and Global Elevations of [Ca2+]i
We tested this idea by comparing exocytosis evoked by brief
voltage-clamp pulses with that elicited by a global increase in
Figure 5. Comparison of Normalized Ca2+ Increases during Short
and Long Stimulation under Varying Conditions of EGTA Buffering
(A) Evanescent field illumination of a voltage-clamped b cell infused with EGTA
(50 mM) stimulated by first a single 50 ms (Aa) and subsequently a 500 ms (Ab)
depolarization from 70 to 0 mV. Changes in [Ca2+]i are displayed in pseudo-
colors with black/blue and yellow/red corresponding to very low and high
concentrations, respectively. Scale bars, 1 mm.
(B) Mean normalized [Ca2+]i increases (n = 4 cells).
(C and D) Same conditions as in (A) and (B) except that 10 mM EGTA was
included in intracellular medium (n = 4). (A)–(D) were performed on control cells.
(E) Comparison of DCm increases evoked by single 50 ms or 500 ms depolar-
izations to 0 mV in the presence of low intracellular EGTA (50 mM EGTA) as
shown in Figure 3A were compared to responses elicited by a 500ms depolar-
ization in the presence of 10 mM at low (50 mM EGTA) or high (10 mM EGTA)
Ca2+ buffering for both control (black; n = 9) and palmitate-treated (red,
n = 10) cells. Inset shows exocytosis elicited by 500 ms depolarization (0 mV)
in the presence of 10 mM intracellular EGTA in control (black) and palmitate-
treated (red) cells. *p < 0.05. All error bars are ±SEM.r Inc.
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Affects Exocytosis Elicited by Voltage-
Clamp Depolarizations and Photoliberation
of Caged Ca2+
(A) Representative recordings of membrane
capacitance (DCm) in control (black) and palmi-
tate-treated (red) cells (bottom) and in response
to a train of five 40 ms depolarizations from 70
to 0 mV (Vm, top) followed by photoliberation of
caged Ca2+ by a flash of UV light (lightning) in a
control cell and a palmitate-treated cell. Measure-
ments of membrane currents (middle) are also
shown.
(B) Average increases in membrane capacitance
(DCm) in response to each 40 ms depolarization
to zero mV, the total increase evoked by the train
(Strain) and themagnitude of the rapid component
of capacitance increase produced by photolibera-
tion of caged Ca2+ (flash) in control cells (black,
n = 11) and palmitate-treated cells (red, n = 11;
*p < 0.05 and **p < 0.01).
(C) Average capacitance changes elicited during
the first 500 ms by photoliberation of caged Ca2+
in control cells (black; n = 11) and palmitate-
treated cells (red; n = 11). For clarity, standard
errors are only shown for every twentieth data
point. The horizontal line indicates the prestimula-
tory baseline.[Ca2+]i produced by photoliberation of ‘‘caged’’ Ca
2+ from
Ca2+—NP-EGTA in control and palmitate-treated cells (Fig-
ure 6A). Cells were first stimulated with five 40 ms depolariza-
tions to 0 mV. In control cells, the first two to three pulses of
the train evoked significant exocytosis, whereas the responses
in palmitate-treated cells were almost abolished. Some recovery
of exocytosis was observed in palmitate-treated cells during the
fifth pulse, presumably reflecting accumulation of [Ca2+]i within
the cell (cf. Figure 3B). In both control and palmitate-treated
cells, photoliberation of caged Ca2+ elicited robust exocytotic
responses. Figure 6B summarizes the average responses for
each pulse of the train, the total increase evoked by the train
(Strain) and the response to photoreleasing caged Ca2+ (flash).
During the first three pulses, exocytosis was inhibited by
>65%, whereas the responses elicited by uncaging of [Ca2+]i
were almost identical. The increases in DCm elicited by photore-
lease could be reasonably fit by double exponentials with time
constants of 23 ± 5 ms and 497 ± 213 ms (n = 10) in control cells
and 26 ± 4 ms and 920 ± 290 ms (n = 11) in palmitate-treated
cells. The corresponding increases in DCm for the rapid and
slow components of exocytosis averaged 85 ± 5 fF and 130 ±
38 fF in control cells and 91 ± 3 and 112 ± 39 fF in palmitate-
treated cells. We conclude that pretreatment with palmitate
inhibits insulin exocytosis by affecting the location of Ca2+ influx
rather than the Ca2+ sensitivity of exocytosis.
Pharmacological Correction of the Inhibitory Action
of Palmitate Exposure on Insulin Secretion
The capacitance measurements and the optical imaging of
exocytosis in single b cells suggest that palmitate treatmentCell Mselectively interferes with rapid exocytosis by disrupting the tight
functional association between the secretory granules and the
Ca2+ channels, whereas that elicited by longer stimuli is unaf-
fected. If the suppression of glucose-evoked insulin secretion
from intact pancreatic islets also results from this effect, then
experimental maneuvers that expand the boundaries of [Ca2+]i
microdomains should rescue insulin secretion. To test this
idea, we used the K+ channel blocker tetraethylammonium
(TEA), which markedly prolongs the b cell action potential
(Atwater et al., 1979). In intact islets cultured for 72 hr, the dura-
tion of the action potentials observed in the presence of 20 mM
glucose alone and following addition of 20 mM TEA averaged
31 ± 1 (n = 3) and 326 ± 17 ms (n = 4), respectively (Figure 7A).
In agreement with previous studies (Olofsson et al., 2007), expo-
sure of mouse islets to palmitate for 72 hr reduced insulin secre-
tion in response to 20 mM glucose by60%. TEA (20 mM) stim-
ulated insulin secretion in both control and palmitate-treated
islets (Figure 7B). Importantly, TEA also corrected the secretion
defect induced by palmitate; in the presence of the K+ channel
blocker, insulin secretion in control and palmitate-treated
islets was not different. The reduction of glucose-stimulated
insulin secretion could not be attributed to a palmitate-induced
decrease in insulin content, which averaged 107% ± 8%
(n = 12) of its control value. Basal secretion in 1 mM glucose
was marginally stimulated in palmitate-treated cells compared
to control islets, and TEA had only a weak effect under these
conditions. Long-term exposure to palmitate also reduced
glucose-induced insulin secretion from human islets (Figure 7C)
without affecting insulin content (104% ± 16% of control islets;
n = 6). This inhibition was also counteracted by TEA.etabolism 10, 455–465, December 2, 2009 ª2009 Elsevier Inc. 461
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Palmitate-Treated Islets
(A) Action potentials recorded from intact islets in the presence of 20 mM
glucose alone (top) and after addition of 20 mM TEA (lower). Examples shown
were recorded from a palmitate-treated islet, but similar effects on action
potential duration were observed in control cells.
(B and C) Measurements of insulin secretion during static incubation of iso-
lated mouse (B, n = 6 [1 mM glucose + TEA] or n = 15 [all other conditions])
or human (C, n = 6 with islets from two donors) islets with 1 or 20 mM glucose
in the absence and presence of TEA as indicated during a 1 hr incubation.
*p < 0.05,**p < 0.01,***p < 0.001.
(D) Dynamics of glucose-induced insulin secretion in control (black) and palmi-
tate-treated islets (red). *p < 0.05 versus control (n = 7 for both conditions). All
error bars are ±SEM.462 Cell Metabolism 10, 455–465, December 2, 2009 ª2009 ElsevWe finally investigated the effects of palmitate exposure on the
kinetics of glucose-induced insulin secretion from mouse islets
(Figure 7D). In control islets, glucose (20 mM) produced a
30-fold stimulation of insulin secretion that peaked after 5 min
and later stabilized at a somewhat lower plateau (20-fold higher
than basal). In islets that had been treated with palmitate,
glucose-stimulated insulin secretion was inhibited by 60%
throughout the stimulation period.
DISCUSSION
Here we show that the inhibitory effect of long-term exposure to
palmitate on insulin secretion is associated with alterations in the
microdomains of Ca2+ entry in b cells. This leads to a selective
inhibition of exocytosis triggered by brief (<100ms) action poten-
tial-like depolarizations. Although the b cell contains a large
number of release-competent granules, only those in close prox-
imity to the voltage-gated Ca2+ channels are released during
b cell electrical activity. We have previously proposed that
Ca2+ channels are physically tethered to the insulin granules
(Wiser et al., 1999). Thanks to this arrangement, a subset of
release-competent granules are exposed to the very high
[Ca2+]i that occurs in the close vicinity of the Ca
2+ channel. Our
data suggest that palmitate causes disassembly of the tight
complexes of Ca2+ channels and weakens the Ca2+ microdo-
mains that form and trigger insulin exocytosis. Under control
conditions, the close proximity of Ca2+ channels and secretory
granules ensures that exocytosis is triggered by the localized
increases in [Ca2+]i evoked by an action potential (Figure S4A).
Following palmitate treatment, however, the increase in [Ca2+]i
does not reach sufficiently high concentrations close to the
secretory granule to produce exocytosis. This would explain
the strong inhibition of exocytosis during action potential-like
stimulation as well as the much greater inhibition of exocytosis
caused by strong Ca2+ buffering (Figure 5E). This scenario also
accounts for the failure of tolbutamide to correct the secretion
defect (Olofsson et al., 2007). This is because tolbutamide trig-
gers brief action potentials of the same type as those occurring
in response to glucose (Henquin and Meissner, 1982).
We emphasize that insulin secretion from palmitate-treated
b cells is not inhibited as a consequence of reduced release
competence (Figure 6C). The fact that exocytosis during 250 ms
depolarizations is unaffected is also consistent with the idea that
FFAs suppress glucose-induced insulin secretion by disruption
of the tight coupling between Ca2+ channels and the secretory
granules. During such long depolarizations, [Ca2+]i equilibrates
within the cell and exocytosis will no longer be restricted to
the immediate vicinity of the Ca2+ channels. This accounts for
the ability of TEA, which leads to a marked prolongation of the
b cell action potential, to restore insulin secretion in palmitate-
treated islets to control values.
It may seem surprising, given that rapid exocytosis is selec-
tively affected in the capacitance measurements and optical
imaging experiments, that first-phase and second-phase insulin
secretion are similarly affected (Figure 7D). Accumulating evi-
dence suggests that first-phase insulin secretion reflects exocy-
tosis of granules residing in close proximity to the voltage-gated
L-type Ca2+ channels (RRP) (Rorsman and Renstrom, 2003; but
see Pedersen and Sherman, 2009; Shibasaki et al., 2007). Onceier Inc.
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must be replenished by physical mobilization of new granules
to the Ca2+ channels and/or lateral movement of the Ca2+ chan-
nels to docked granules (Figure S4B). Importantly, both first- and
second-phase insulin secretion are triggered by the Ca2+ influx
during the brief action potentials, and they occur at a frequency
too low to allow major summation of the individual [Ca2+]i tran-
sients (Figure 3B). First-phase insulin secretion is normally larger
than the second phase because the rate at which RRP is replen-
ished is lower than the maximum secretory capacity.
We emphasize that our data do not exclude the possibility that
other adverse effects (including increased cell death [Eizirik
et al., 2008] and mitochondrial uncoupling [Joseph et al.,
2004]) ultimately develop during protracted hyperlipidemia and
contribute to the impaired insulin release. It is pertinent, how-
ever, that the mechanism we describe here, that results in
reduced Ca2+-dependent exocytosis, develops within 72 hr and
occurs before the other functional abnormalities are detectable.
What causes the Ca2+ channels to dissociate from the secre-
tory granules?Our data indicate that this is not a consequence of
altered membrane fluidity. Previous work (Barg et al., 2001)
suggests that the tethering of the secretory granules to the
Ca2+ channels involves the interaction of the synprint peptide
(the cytoplasmic domain connecting the second and third
homologous domain of the L-type Ca2+ channel) with the exocy-
totic core complex consisting of syntaxin-1, synaptotagmin, and
SNAP-25. In mouse insulinoma MIN6 cells, long-term exposure
to palmitate alters the expression of several proteins involved
in b cell exocytosis (Lovis et al., 2008). Mice lacking syntaxin-
1a exhibit a reduced number of docked granules and loss of
first-phase insulin secretion but normal second-phase release
(Ohara-Imaizumi et al., 2007), but our own data did not reveal
any abnormalities in the expression or distribution of syntaxin-1
(Figure S3) or SNAP-25 (Zraika et al., 2004). There were likewise
no major changes in the transcription of other exocytotic
proteins/Ca2+ channel subunits that would explain the functional
data (Table S1). Clearly, mRNA levels need not equate to protein
levels. Chronic exposure to palmitate results in increased
expression of the microRNA miR34a (Lovis et al., 2008). Micro-
RNAs act by inhibition of translation and may consequently
affect protein expression even in the absence of any changes
in gene transcription. It should be noted, however, that long-
term exposure to palmitate has no effect on rapid exocytosis
elicited by photorelease of caged Ca2+ (Figure 6). This makes it
less likely that the suppression of insulin secretion reflects
reduced expression of key exocytotic proteins. Alternatively,
chemical modification of these proteins, via changes in acylation
(Yajima et al., 2000) or palmitoylation (Fukata et al., 2006) result-
ing from the altered phospoholipid composition of the plasma
membrane (Figure 1), may interfere with the stability of the
granule/Ca2+ channel complexes. This will be challenging to
examine, as the pharmacological inhibitors of acylation have
numerous side effects including inhibition of glucosemetabolism
(Straub and Sharp, 2007).
What is the physiological rationale for the ability of lipids to
interfere with the association of secretory granules and Ca2+
channels in b cells? Importantly, short-term (2 hr) exposure to
palmitate (which stimulates insulin secretion; Olofsson et al.,
2004) did not affect Ca2+ channel clustering (Figure 2C). Thus,Cell Mthe effect is only observed during protracted exposure. Long-
term elevation of plasma FFAs occurs physiologically during
fasting, when the plasma FFA concentration may increase to
1.5 mM (review, Frayn, 2003). In vivo recordings of b cell elec-
trical activity have shown that the increased plasma FFA associ-
ated with fasting leads to stimulation of b cell action potential
firing but suppression of insulin secretion (Fernandez and Val-
deolmillos, 1998). Thus, the normal correlation between b cell
electrical activity and insulin secretion is lost when plasma FFA
levels are chronically elevated. Our data suggest that this results
from a lipid-induced dissociation of Ca2+ channels from the
secretory granules. It is tempting to speculate that this repre-
sents an evolutionarily conserved catabolic mechanism that
suppresses insulin secretion. If it were not for this mechanism,
elevation of FFAs would stimulate insulin secretion at plasma
glucose levels found during protracted fuel withdrawal: 3.5 mM
in man (Frayn, 2003) and 4.5 mM in mice (Fernandez and Val-
deolmillos, 1998). However, this mechanism may backfire, at
least in genetically predisposed individuals (Kashyap et al.,
2003), when plasma lipids become chronically elevated as
a consequence of a high-fat diet or impaired insulin secretion.
Once this has occurred, it is easy to envisage a vicious cycle
resulting in progressive deterioration of insulin secretion and
elevation of plasma FFAs culminating in glucose intolerance
and overt diabetes.
EXPERIMENTAL PROCEDURES
Tissues and Cell Isolation, Electrophysiology, Hormone Release
Measurements, Adenoviral Infection, and Composition of Media
All animal experiments were carried out on standard laboratory CD-1 mice.
Human islets were obtained from the Oxford Islet Isolation Centre. Previously
described methods were used for preparation of islets and single b cells, elec-
trophysiology, and insulin release measurements (Olofsson et al., 2007).
Palmitate was prepared in a solution bound to fatty acid-free bovine serum
albumin (BSA). Palmitate was dissolved in 95% ethanol, and stoichiometric
amounts of NaOH were added. The solution was dried using nitrogen gas;
water was subsequently added and the solution heated to create a hot
soap. The solution was stirred and BSA was added to a final concentration
of 10%w/v, to create a 10x stock solution. The pHwas set to 7.4 (NaOH). Islets
were cultured in RPMI 1640 together with 0.5 mM palmitate in the presence
of 1% BSA for 72 hr. The resulting free FFA concentration was estimated to
be 26 nM. Control islets were cultured in the presence of 1% BSA alone.
Islet perifusions were performed using an in-house-designed system with
four temperature-controlled chambers. Fifty size-matched islets were trans-
ferred onto a 1 mm nylon mesh cut to the size of the chamber, which was filled
and perfused continuously with extracellular medium containing (in mM)
120 NaCl, 4.7 KCl, 25 NaHCO3, 1.2 KH2PO4, 1.2 MgSO4, 10 HEPES (pH 7.4
with NaOH), 2.5 CaCl2, 0.5 mg/ml BSA, and D-glucose as indicated. The
chamber temperature was kept at 37C. Samples were collected in
96-deep-well format plates every 30 s and kept at 20C pending insulin
measurements.
Expression of IAPP-mCherry was achieved by adenoviral infection using an
in-house vector modified to express the mCherry fluorophore. Homologous
recombination of the vector into the adenovirus was performed by Vector
BioLabs (Philadelphia, USA).
The standard extracellular medium for imaging and electrophysiological
measurements consisted of (in mM) 138 NaCl, 5.6 KCl, 1.2 MgCl2,
2.6 CaCl2, 5 HEPES, and 5 D-glucose at pH 7.4 (adjusted with NaOH). The
intracellular solution consisted of (in mM) 125 Cs-glutamate, 10 CsCl,
10 NaCl, 1 MgCl2, 0.05 EGTA, 3 Mg-ATP, 0.1 cAMP, 5 HEPES (pH 7.2 using
CsOH), and 0.03 Oregon Green 6F. In Figures 2, 5D, and 5E, intracellular
Ca2+ buffering was increased by adding 10mMEGTA (with iso-osmolar reduc-
tion of 10 Cs-glutamate).etabolism 10, 455–465, December 2, 2009 ª2009 Elsevier Inc. 463
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(Rapp Optoelektronik GmbH, Hamburg, Germany). The pipette solution
consisted of (mM) 110 K-glutamate, 10 KCl, 20 NaCl, 1 MgCl2, 25 HEPES
(pH 7.1 with KOH), 3 MgATP, 3 NP-EGTA (Synaptic Systems, Goettingen,
Germany), and 2 CaCl2. The low-affinity Ca
2+ indicator Oregon Green 6F
was included in this medium at a concentration of 0.03 mM.
All solutions were osmotically balanced to between 290 and 310 mOsm.
Experiments were performed at +32C (electrophysiology) or +37C (hormone
release).
Imaging of Exocytosis and [Ca2+]i
Images were obtained with a customized Olympus IX-81 total internal reflec-
tion fluorescence (TIRF) microscope equipped with a 1503/1.45 Apo lens
(Olympus, UK). The 488 nm line of an argon ion laser (Melles Griot, Germany)
was used to excite the Ca2+ dye Oregon Green 6F (Invitrogen, Carlsbad, USA),
and a 561 nm line of a steady-state diode laser was used to excite IAPP-
mCherry. Two excitation ports with separate focal pathways were used to
make independent adjustments of each laser. The emission pathway for
both fluorescent reporters was imaged simultaneously with an image splitter
(Dual View, Optical Insights, Santa Fe, NM, USA) creating side-by-side images
of both emission wavelengths on the chip of a charge-coupled device (CCD)
camera (Cascade II 512B, Roper Scientific, Trenton, NJ, USA). All images
were acquired using Cell^R software (Olympus, UK) and later analyzed with
MetaMorph software version 7.53 (Universal Imaging, Downingtown, PA,
USA). Images were acquired at 20–30 Hz with 10 ms excitation exposure.
To correct for alignment between the two channels, live images were adjusted
by hand to align the emission pathway to overlap in both channels by imaging
200 nm tetraspeck beads (Molecular Probes, Eugene, OR). This correction
was done on a daily basis.
Fatty Acid Analysis and Isotopic Enrichment
Total phospholipids and triglycerides were separated by spotting lipid extracts
onto silica gel 60 (Merck) thin-layer chromatography plates using hexane:
diethyl ether:acetic acid (85:15:1 vol/vol/vol) as the solvent (Folch et al.,
1956). Lipid bands were visualized under UV light after spraying with 0.1%
ANS (8-anilino-1-naphthalene sulphonic acid). Identification was verified using
commercial standards. Total phospholipid and triglyceride bands were trans-
ferred into glass tubes andmethylated at 80Cwith 1.5% (triglycerides, 2 hr) or
6% H2SO4 (phospholipids, 12 hr) in methanol. Total phospholipid and triglyc-
eride fatty acids were eluted into hexane. Separation and quantification of the
fatty acid methyl esters (FAMEs) from islet total phospholipids and triglyceride
were achieved using gas chromatography (Agilent 6890 GC, Agilent Technol-
ogies, UK) fitted with a 30 m3 0.53 mm (film thickness 1 mm) capillary column
(RTX-Wax). Individual fatty acid peaks were identified by reference with known
FAMEs. Fatty acid compositions (mmol/100 mmol total fatty acids; mol%) in
these peaks were then determined.
[U-13C] enrichment was determined by GC-mass spectrometry (GC-MS)
using a 5890 GC coupled to a 5973N MSD (Agilent Technologies, UK). The
GC was equipped with a 30 m 3 0.25 mm (film thickness 0.25 mm) capillary
column (rTX-5) and ions with mass-to-charge ratios (m/z) of 270 (palmitate;
M+0) and 286 (i.e., palmitate uniformly labeled with 13C; M+16) were deter-
mined by selected ionmonitoring. Dwell time was 100ms. Tracer-tracee ratios
(TTRs) for [U-13C]palmitate (M+16)/(M+0) were multiplied by the correspond-
ing PL or TG fatty acid concentrations to give islet tracer concentrations.
Data Analysis
Measurements of the rate of exocytosis (Figure 4E) as well as the magnitude of
release (Figures 3C and 3D) were compared between cells by normalizing to
the percentage of released granules ([number released]/[number visible]).
Granules were identified by an automatic Metamorph routine that identified
all ‘‘spots’’ between 400 and 900 nm in diameter with brightness >15% above
the local background of surrounding pixels. For the total granule count, large
clusters of bright granules were ignored: these accounted for8% of all gran-
ules in both control and palmitate-treated cells.
For measurements of Ca2+ influx (Figure 2), the standard deviation (s) and
mean fluorescence (m) were measured for the entire cell footprint, which was
determined from the basal fluorescence of the Oregon Green 6F dye infusion.
The CV,measured as the ratio betweens and m, was determined bymeasuring464 Cell Metabolism 10, 455–465, December 2, 2009 ª2009 Elseviethe Ca2+ signal within the footprint during membrane depolarization after sub-
tracting the average resting Ca2+ signal. The resting signal for each depolariza-
tion was calculated by averaging the four frames recorded prior to depolarizing
the cell. The average background image thus generated was then subtracted
from that obtained during depolarizations. Increases in [Ca2+]i (measured as
DF) around exocytosing granules weremeasuredwithin 1 mmdiameter circular
regions centered on the location of all identified exocytotic events within a cell
(identified by the optical increase and dispersion of IAPP-mCherry fluores-
cence that occurred in a separate, but aligned, optical channel). These local-
ized increases were then compared to increases of [Ca2+]i within adjacent,
but nonoverlapping (>1.5 mm but <2 mm) regions around granules that did
not undergo exocytosis. To correct for irregularities in the evanescent field
and amount of membrane within a measured region, all measurements of
[Ca2+]i increases (DF) were normalized to basal fluorescence (F) levels prior
to depolarization for each region.
Data are presented as mean values ± SEM for the indicated number of
experiments (n). Statistical significance measurements were performed by
Student’s t test, with Bonferroni corrections in Table S1, and in Figures 1
and 7 an ANOVA test with Dunnet C post-hoc adjustments.
SUPPLEMENTAL DATA
Supplemental Data include four figures, one table, and one movie and can
be found with this article online at http://www.cell.com/cellmetabolism/
supplemental/S1550-4131(09)00307-6.
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